EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear and consensual international recommendations on RA treatment are not available. In this paper recommendations for the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (DMAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolen, Josef S, Landewé, Robert, Breedveld, Ferdinand C, Dougados, Maxime, Emery, Paul, Gaujoux-Viala, Cecile, Gorter, Simone, Knevel, Rachel, Nam, Jackie, Schoels, Monika, Aletaha, Daniel, Buch, Maya, Gossec, Laure, Huizinga, Tom, Bijlsma, Johannes W J W, Burmester, Gerd, Combe, Bernard, Cutolo, Maurizio, Gabay, Cem, Gomez-Reino, Juan, Kouloumas, Marios, Kvien, Tore K, Martin-Mola, Emilio, McInnes, Iain, Pavelka, Karel, van Riel, Piet, Scholte, Marieke, Scott, David L, Sokka, Tuulikki, Valesini, Guido, van Vollenhoven, Ronald, Winthrop, Kevin L, Wong, John, Zink, Angela, van der Heijde, Désirée
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Ejemplares similares